Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Protection Against Parkinson’s—How the DJ Changes Station
7 June 2004. Mutations in the gene for the protein DJ-1 are known to cause early-onset Parkinson’s disease (see ARF related news story). Exactly what DJ-1 does is unknown, however, so how the wild-type protein protects against the disease is unclear. Theories abound, some of the favorites suggesting that the protein is a protease, or that it protects against oxidative stress (see ARF related news story). Some new evidence supports the latter theory. In this week’s early online PNAS, Mark Cookson and colleagues at the National Institute on Aging, Bethesda, Maryland, and Brandeis University, Massachusetts, show that a redox switch prompts the movement of DJ-1, normally stationed in the cytosol, to the mitochondria.

DJ-1 has been shown to convert to a more acidic, negatively charged protein in response to oxidative stress, and some indications suggest that this is due to oxidation of a cysteine sulphydryl group to sulfinic acid. To put this theory to the test, first author Rosa Canet-Aviles and colleagues mutated each of the cysteines to alanine.

When these mutants were expressed in cells producing reactive oxygen species (ROS), only one of the proteins, with the mutation at amino acid 106, failed to convert to the more acidic form. The finding indicates that this particular cysteine may be the one that is oxidized to sulfinic acid. This is backed up by crystallographic evidence. The authors found that electron density maps of crystals of the wild-type protein were entirely consistent with a sulfinic group at cysteine 106.

What might be the physiological significance of this cysteine redox switch? To answer this, the authors compared the localization of wild-type and the C106A mutant. They found that unlike wild-type protein, the mutated protein did not localize to mitochondrial outer membranes in response to oxidative stress. This in turn may be related to the protein’s ability to protect cells against oxidative damage. When the authors exposed cells to MPTP, a chemical that damages mitochondria—and as a contaminant in synthetic heroin has caused Parkinsonism in drug abusers (see ARF related news story)—about 95 percent of wild-type cells survive, while only about 60 percent of cells expressing the C106A mutant do so.

Overall, the work suggests that DJ-1 responds to a redox switch and is then translocated to the outer membrane of the mitochondria. But many questions remain. How does oxidation of one cysteine to sulfinic acid cause translocation? And what does the protein do once it gets to the mitochondria?

Interestingly, a sulphydryl-to-sulfinic switch was just recently found in another class of proteins that is implicated in preventing oxidative stress. In the peroxiredoxins, a cysteine sulphydryl, which is part of the catalytic core, is converted to a sulfinic group, and this switch is accompanied by conversion of the protein from a low molecular weight redox enzyme, to a high molecular weight chaperone (see ARF recent related news story).

Lots of recent evidence points the finger squarely at reactive oxygen species as mediators of disease and a whole host of proteins as regulators of oxidative stress and potential attenuators of disease. The latter include DJ-1, peroxiredoxins, and pink1, a protein that causes Parkinsonism when mutated and which is located to the mitochondria (see ARF related news story), while wholesale disruption of mitochondrial transcription has been shown to cause late-onset neurodegeneration (see ARF related news story).—Tom Fagan.

Reference:
Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, Bandyopadhyay S, Baptista KJ, Ringe D, Petsko GA, Cookson MR. The Parkinson’s disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial relocalization. PNAS 2004 May 31 early online edition. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad